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Abstract
Background: Gene expression patterns in the brain are strongly influenced by the severity and
duration of physiological stress at the time of death. This agonal effect, if not well controlled, can
lead to spurious findings and diminished statistical power in case-control comparisons. While some
recent studies match samples by tissue pH and clinically recorded agonal conditions, we found that
these indicators were sometimes at odds with observed stress-related gene expression patterns,
and that matching by these criteria still sometimes results in identifying case-control differences
that are primarily driven by residual agonal effects. This problem is analogous to the one
encountered in genetic association studies, where self-reported race and ethnicity are often
imprecise proxies for an individual's actual genetic ancestry.
Results: We developed an Agonal Stress Rating (ASR) system that evaluates each sample's degree
of stress based on gene expression data, and used ASRs in post hoc sample matching or covariate
analysis. While gene expression patterns are generally correlated across different brain regions, we
found strong region-region differences in empirical ASRs in many subjects that likely reflect inter-
individual variabilities in local structure or function, resulting in region-specific vulnerability to
agonal stress.
Conclusion: Variation of agonal stress across different brain regions differs between individuals,
revealing a new level of complexity for gene expression studies of brain tissues. The Agonal Stress
Ratings quantitatively assess each sample's extent of regulatory response to agonal stress, and allow
a strong control of this important confounder.
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Background
Comparing cases and controls is one of the most widely
used methods in genetic and epidemiological research to
identify disease risk factors at the population level. From
the study design standpoint, to maximize the power of
detecting a true effect it is important to understand the
major sources of phenotypic variation, and to minimize
sample heterogeneity accordingly. Furthermore, to reduce
the number of spurious positive findings due to con-
founding factors, it is important to match cases and con-
trols on "well-established determinants" [1] that are not
themselves the variables of direct interest. In practice,
however, it is often difficult to declare a priori which vari-
ables, out of many that are examined, are the established
risk factors. Occasionally, the major factors affecting the
phenotypic outcome may be truly strong and well known,
such as cigarette smoking as a risk factor for lung cancer,
or older age for Alzheimer's disease. In most other situa-
tions, however, particularly those concerning multifacto-
rial diseases such as cancer and psychiatric disorders, there
are usually numerous contributing factors for the
observed phenotype, but their relative importance is not
always known beforehand. While many case-control stud-
ies automatically include age and gender in sample
matching, additional variables that are important for the
phenotype need to be chosen on a case-by-case basis, and
sometimes only after the data have been collected and
analyzed. In genetic association studies, for example, the
ancestral background of human subjects can have a strong
confounding effect [for example, [2-5]]. A parallel situa-
tion exists for gene expression analyses involving the use
of postmortem samples, where tissue pH and near-death
physiological stress can exert a major influence on the
inter-individual variation of expression patterns [6,7]. The
impact of pH/agonal stress is so strong that it often far
outweighs the influence of all other factors, including age
and gender, and can obviate the detection of the impact of
the illness. Because of this, more and more gene expres-
sion studies in recent years take special precaution to
match samples by pH and agonal factors, just as a well
designed genetic study seeks to balance cases and controls
by self-reported racial identity or continental ancestry.
Despite the widespread use and general success of these
sample matching strategies, the risk of residual confound-
ing remains. The key pH-sensitive genes or pathways, such
as components of mitochondrial electron transport chain
and proteasome genes, are highly variable between sam-
ples [8], and often appear as the top findings in microar-
ray-based case-control comparisons of brain samples. For
example, while several studies have reported down-regu-
lation of mitochondrial transcripts in schizophrenia [9]
and bipolar disorder [10], others have reported up-regula-
tion [11,12]. The samples used by Prabakaran et al. [9]
had a slight case-control difference in pH, but many more
controls than cases died of cardiac events [13]. Further
analyses of the same RNA samples suggested that most of
the findings that implicate mitochondria genes could be
explained by effects of medication. Interestingly, the sam-
ples used in Sun et al. [10] were not balanced in pH,
although the clinical condition appeared to be balanced.
These conflicting results suggest that the role of pH-sensi-
tive, stress-related genes in psychiatric disorders is still
unresolved. Similarly, in the parallel example of genetic
association studies, several recent analyses have high-
lighted the need for more stringent controls for the very
strong genetic confounders [3,4]. In studies involving
highly diverse populations, many human subjects are
admixed at the individual level, that is, they carry genetic
material derived from several founding populations. For
such individuals, a single self-reported racial or ethnic
descriptor such as "African American" or "Hispanic" is no
longer adequate for representing the proportional contri-
bution from multiple ancestral origins. It has become
more desirable, and in fact feasible, to infer the individual
admixture ratios from the observed genetic data [14-16],
and to apply these empirically derived ratios in post hoc
sample matching [17,18]. In effect, what was initially a
sample classification problem, in which subjects are cate-
gorized into discrete ethnic groups, has been turned into
a "grades of membership" problem [19], in which indi-
vidual samples are scored on one or several continuous
variables. These continuous variables can be used for sam-
ple selection, case-control matching, or as a new covariate
in regression analyses, stratified analyses, or ordered sub-
set analyses [20-22]. The empirically derived ancestral
ratios may be more effective for mitigating the impact of
confounding, because they can be more accurate than self-
reported ancestry, as the former are derived from the
genetic data per se, and are less susceptible to survey errors
or recall bias.
In this study, we applied a similar strategy to an ongoing
gene expression study in which we compare postmortem
brain tissues between normal controls and subjects who
suffered from major depression, bipolar disorder, or
schizophrenia. In a previous report [6], we described a
classification-based analysis in which gene expression pat-
terns in most subjects can be assigned to one of two main
types: one from a low-pH, highly stressed group of sam-
ples, named "Type 2", and the other from a normal-pH,
low-stress group of samples, named "Type 1". These two
prototypes of expression patterns can be distinguished by
strong and systematic changes in several biological path-
ways, including genes involved in energy metabolism and
stress response. Since that report, we have increased the
scope of our investigation from three brain regions in 40
subjects to six regions in up to 126 subjects (some regions
were studied in fewer than 126 subjects). In carrying out
case-control analyses, we found that even among the sup-BMC Genomics 2007, 8:336 http://www.biomedcentral.com/1471-2164/8/336
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posedly "purified" subset consisting of only the Type 1
samples, some residual heterogeneity in pH/agonal stress
may still be driving the case-control comparison results,
largely because of the overwhelming impact of agonal
stress. Meanwhile, the pH- and stress-related genes that we
and others have characterized continue to appear in the
literature as among the top gene expression findings in
comparative studies for a variety of diseases and condi-
tions [9,23]. This experience motivated us to seek finer
control of this obscuring variable by characterizing sam-
ple heterogeneity in greater detail. Specifically, we refined
our previous dichotomous classification scheme to one
that evaluates group-membership by quantitative ratings.
A second rationale for pursuing this study came from the
recognition that pH values are typically measured in one
or two brain regions (in our case, cerebellum), whereas
disease-related changes in gene expression are expected to
occur in numerous brain regions. There is no a priori rea-
son to assume that altered pH and agonal factors would
impact all these brain regions in a uniform manner. Con-
sequently, sample matching based on a parameter derived
from a single brain area or the entire brain may not be reli-
able for all regions examined, whereas gene expression
data for individual regions can be used to assess specific
regional patterns of agonal stress.
To this end, we developed Agonal Stress Rating (ASR), a
quantitative system that measures the degree of stress of
each RNA sample on a continuous scale based on gene
expression data. We examined the relationship between
ASRs and conventional pre hoc indicators such as pH and
clinically derived Agonal Factor Scores (AFS), compared
the stress ratings across six brain regions, and assessed the
performance of different sample matching strategies. We
also developed rigorous data pre-processing methods,
compared different options of defining the ASRs, evalu-
ated the robustness of ASRs in terms of the between-lab
and between-platform reproducibility, and explored sev-
eral related analysis algorithms.
Results
Systematic technical variation and data processing 
strategies
Before we begin to characterize biological confounding
factors, non-biological sources of variation must be iden-
tified. The microarray data used in this study were col-
lected in multiple experimental batches, representing the
mixed use of two types of Affymetrix Genechips (U133A/
B and U133Plus_2), experiments run at three laboratories
(at UC Irvine, UC Davis, and University of Michigan),
RNA samples from six brain regions (AnCg, DLPFC, AMY,
HC, CB, and NACC), and six cohorts of approximately 20
subjects each (four Mood Disorder Cohorts and two
Schizophrenia Cohorts), for up to 126 subjects, about half
of which were normal controls, the other half were cases
of major depression, bipolar disorder, or schizophrenia.
Cohort assembly, tissue dissection and RNA extraction
took place in multiple stages, typically several months
apart. The RNA samples were labeled and hybridized one
cohort at a time, one region at a time, in two or three lab-
oratories (called "Sites", not to be confused with the six
brain regions) separately. As a result of these technical var-
iabilities, the entire dataset contained systematic differ-
ences between sites, chip types, and sometimes, cohorts,
although the cohort-cohort technical differences are
blended with genuine sample-sample differences across
cohorts. This type of technical variation warrants careful
scrutiny, and must be adequately controlled to ensure the
accuracy of analyzing biological differences.
After array scanning and Affymetrix Genechip data sum-
mary (a computational process that combines data from
multiple oligonucleotides probes designed to interrogate
a given transcript to obtain a single expression value for
that transcript, see Methods for more details), we exam-
ined chip-to-chip similarity in each region by plotting the
pairwise correlation matrices as color-coded heatmaps,
where red indicates high similarities between pairs of
chips, blue indicates low similarity, and the samples are
ordered by site and by cohort. Figure 1a showed one such
correlation map for 201 AnCg chips produced by using
logged intensities of all 12,734 Refseq gene-based probe
sets on the U133A chip. In this example, as is the case for
other brain regions, we analyzed data from two sites in
our Consortium for six cohorts, representing 12 naturally
occurring experimental batches. Figure 1a shows that the
observed patterns aggregate in rectangular "blocks" of
high correlation, indicated in red, corresponding to sam-
ples that are highly similar to each other in gene expres-
sion patterns. Importantly, the block-block partition
coincides with the natural boundaries of experimental
batches. Not all experimental batches can be definitively
separated from each other; typically the 12 batches can be
adequately described by 5–9 blocks, as sometimes two
adjacent cohorts from one site form a single indistinguish-
able group, mostly due to relatively homogeneous techni-
cal conditions shared across these cohorts. In all, block-
like structures are seen in every brain region, and almost
always correspond to experimental batches, suggesting
that they arose from changes in reagents, hybridization
protocols, chip types, or scanning conditions.
At least two other lines of evidence suggest that the
"blocks" are derived from technical variation between
experimental batches rather than due to genuine biologi-
cal differences between samples in different cohorts. First,
when we set aside data for all human transcripts, and plot
chip-chip correlations by using only the 68 Affymetrix
control probe sets, which target spiked-in E. coli tran-
scripts, the data still exhibit the same block structure asBMC Genomics 2007, 8:336 http://www.biomedcentral.com/1471-2164/8/336
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Technical "block" effects due to cohort, chip-type, and laboratory (site) Figure 1
Technical "block" effects due to cohort, chip-type, and laboratory (site). a. A color-coded correlation matrix among 
201 AnCg samples. Red indicates high correlation between pairs of samples; blue indicates low correlation. Samples were 
ordered by technical batches, which in turn were defined by Cohort, Chip Type, and Site, as indicated below the heatmap. 
Throughout this paper the sample order in correlation heatmaps is the same from left to right as from bottom to top. Pear-
son's correlations were calculated by using all U133A transcripts. Rectangular "blocks" of high correlation, indicated in red, 
correspond to samples that are highly similar to each other in gene expression patterns. These block-block partitions coincide 
with the natural boundaries of experimental batches as indicated below the heatmap. D1 through D4 indicate Depression 
Cohorts 1 to 4, while S1 and S2 indicate Schizophrenia Cohort 1 and 2. b. The same correlation matrix after removing the 
block effect by median centering each block. The diagonal line of high values are self-self correlations, but the two off-diagonal 
lines of relatively high correlation values are between replicate chips for the same samples ran at two sites. The sample order 
and block partitions are the same as in 1a.
A 
0.94    0.97          1.0 
B 
  -1        0            1 
D1     D2 D3  D4   S1   S2        D1      D2 D3  D4    S1  S2
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seen with the use of all genes [see Additional File 1, figure
1a], indicating that technical factors play a major role in
delineating the blocks. Secondly, when we re-ran all sam-
ples on a custom 711-gene Illumina Beadarrays in a vali-
dation experiment that was done at one site and
randomized samples across cohorts and regions, we did
not observe the block-like separation between cohorts
[see Additional File 1, figure 1b], suggesting that biologi-
cal differences between cohorts made a minor contribu-
tion, if any at all, to the observed "blocks".
The correlation matrices not only provide a means to vis-
ualize sample heterogeneity, but also allowed us to define
a most parsimonious set of blocks for each region for the
purpose of data normalization. To adjust for the block
effect, we subtracted from each sample's logged expres-
sion value the median value of the block, and did so for
each block and for every transcript. For example, for each
gene, expression values for all Block 1 samples would sub-
tract the median value of Block 1, and likewise for all
other blocks, such that after the centering, the median of
each block is at zero, effectively transforming the original
data into the deviations from the block medians, in a pro-
cedure that is similar to adding a Block factor as a categor-
ical variable in robust linear modeling (particularly the
median polish method). The goal of this procedure is to
remove a block-wide fixed factor, most of which, as we
argued above, came from technical sources. The benefit of
this adjustment, particularly the assumption of a fixed
block-specific effect, can be evaluated by an objective cri-
terion: how well the adjusted data increase the technical
reproducibility of the same samples that were run at two
or more sites. We found that after removing the block
effect by median centering, we improved the between-site
similarity for replicate chips run at multiple sites (Figure
1b). For samples that were run on both the U133A and
the U133Plus_2 chips, removing a fixed between-chip-
type effect produced satisfactory agreement between the
two chip types [see Additional File 1, Figure 1c].
Although the systematic differences between blocks can
be adjusted in this way, the assumption of a fixed effect is
not expected to hold for all genes in all samples equally
well. Other types of variation, including within-block het-
erogeneity, however, are not readily discernible in the
data, and are probably impossible to control. Our analysis
showed that a major portion of the between-block differ-
ences have been accounted for by a fixed technical effect
affecting all samples within the block, for most of the
genes studied. In the example of 201 AnCg chips, the
median proportion of variance explained by the "block"
factor, across all 12,734 genes, is 2.5% of the total vari-
ance. Because the 2.5% between-block variance has one
degree of freedom, while the 97.5% within-block variance
has 199 degrees of freedom, the F test showed that more
than half of the genes had significant between-block dif-
ferences. In this case, 56% of the genes satisfy P < 0.05
(one-way ANOVA) for the Block factor.
Biological variation across samples
Previously we showed that most of the brain samples in
our study can be classified into two main types of expres-
sion patterns [6]: those from individuals who died quickly
and had normal tissue pH, and those from individuals
who suffered prolonged death, typically with medical
complications, and exhibited low tissue pH. The thresh-
old value between low and normal pH is around 6.6 in
our samples, but it varied among different studies and dif-
ferent tissue collections [24]. Figure 2a shows the correla-
tion heatmap for the 201 AnCg samples obtained by using
expression values already adjusted for the block effect as
described above. This is the same plot as in Figure 1b, but
with the samples re-ordered so that the previously desig-
nated Type 1 samples are grouped to the lower left side of
the graph. While the distinction between the two classes
can be clearly seen, there are still samples of intermediate
patterns that may correspond to varying degrees of agonal
stress that do not readily belong to the two opposing pro-
totypes.
Because pH/agonal stress acts as an exceedingly strong
confounder in gene expression studies, a dichotomous
classification may not be sufficient to ensure that cases
and controls are well-stratified, or balanced within each
stratus. In addition, different brain regions may carry dif-
ferent stress outcomes; whereas this aspect of data hetero-
geneity is not well informed by pH values measured in
one brain region, nor by the clinical indicators. One pos-
sible approach for dealing with residual heterogeneity is
to subdivide the main classes further, such as into Types
1A, 1B, 2A, 2B, etc, effectively classifying samples in mul-
tiple tiers to establish nested subsets, within each of which
the cases and controls are more homogeneous and better
balanced. Figure 2b shows an example of three-type clas-
sification; however, even finer subdivisions are clearly
possible. In practice, it is difficult to decide the number of
clusters or layers of clusters needed, and the samples often
show genuinely graduated differences of expression pat-
terns. A natural alternative to a finer-grained classification
approach, therefore, is to rate samples on one or several
continuous scales. Toward this goal, we first carried out a
Principal Component Analysis. We re-ordered the 201
AnCg sample by their first principal component (PC1)
scores, and the resulting heatmap (Figure 2c) shows a
gradual transition from one end of the spectrum to the
other. Similarly smooth progressions are also observed for
the other five regions (not shown). Importantly, the PC1
scores are highly correlated with pH (r = 0.59 for AnCg, P
< 10-13), the clinical agonal factors, as well as with the pre-
viously determined Type 1-Type 2 designations; whereasBMC Genomics 2007, 8:336 http://www.biomedcentral.com/1471-2164/8/336
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PC2 and PC3 scores have almost no correlation. For
example, in AnCg, r is 0.04 (P > 0.35) and 0.07 (P > 0.25)
for pH-PC2 and pH-PC3, respectively. Note that with n =
126, r needs only to be approximately 0.18 to be signifi-
cantly non-zero at p = 0.05). This result not only confers a
biological meaning to PC1, but also suggests that a single
continuous variable is likely to be sufficient to capture
most of the gradual progression of expression patterns
from the low-pH prototype to the normal-pH prototype.
Not all genes contributed equally to the placement of
individual samples along the gradient of membership. We
selected the 20% strongest Type 1-like samples (on the
lower left corner of Figure 2c) and the 20% strongest Type
2-like samples (on the upper right corner), and calculated
the Student's t scores that contrasted the group means
between these two canonical groups. This allowed us to
rank genes by their Type 1- Type 2 absolute t scores, with
the "top genes" being those that are most strongly affected
by pH/agonal stress. When we re-plot Figure 2c by using
the 25% strongest pH-sensitive genes (instead of all
12,734 genes), a strong gradient is clearly seen (Figure 3,
upper left panel). The gradient between samples becomes
much dampened when the second 25% of ranked genes
(upper right of Figure 3) is used, and fades away almost
entirely with the use of the third and last 25% of ranked
genes (lower panels of Figure 3). This result indicates that
the top 50% of genes are likely to be informative for mem-
bership inference, with the top 25% and top 5% of genes
carrying increasingly greater discriminating power, as one
would expect. In Additional File 2 we showed a heatmap
of expression levels of the top 25% of transcripts across
201 AnCg samples. These genes have been used to calcu-
late the sample-sample correlations shown in Figure 3,
upper left panel. The genes are ordered from left to right
by their coefficients in the first principal component (i.e.,
the first eigenvector), whereas the samples are ordered
from top to bottom by their first principal component
scores. The actual expression levels are provided in Addi-
tional File 3, which is a .cdt file that can be opened in Java
Treeview for flexible browsing. To estimate the number of
genes significantly affected by the pH effect, we used the
Nearest Shrunken Centroids classifier [25] to calculate the
cross-validation errors in a two-class classification analy-
sis, and examined gene panels containing varying num-
bers of most discriminating genes. Panels having as few as
297 (2.3% of the total of 12,734 probe sets) and as many
as 4,720 (37.1%) genes resulted in eight or fewer cross-
validation errors out of 201 samples, and formed a pla-
teau of error curve [see Additional File 4], indicating a
broad range of the number of informative genes. Simi-
larly, in genetic association studies, some DNA polymor-
phisms are more informative for distinguishing different
populations [26]. In our procedure to construct an Agonal
Stress Rating for individual samples (described below),
From discrete classification to grades of membership Figure 2
From discrete classification to grades of member-
ship. a. The same correlation matrix as in Figure 1b but with 
samples re-grouped so that the Type 1 samples are on the 
lower left side, showing that samples can be classified into 
two main types of expression patterns. b. The same samples 
can be subdivided into three classes, and re-ordered accord-
ingly in the correlation heatmap, still showing reasonably 
strong distinction between the three classes. c. The same 
heatmap re-ordered by the first Principal Component scores, 
resulting in a gradual progression from one prototype to the 
other.
A
B
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Informativeness of genes for agonal stress Figure 3
Informativeness of genes for agonal stress. The same heatmap as shown in 2c but with the correlations calculated by 
using the 25% strongest Type 1-Type 2 genes (upper left), the next 25% (upper right), the third 25% (lower left), and the last 
25% of genes (lower right). The genes were ranked by comparing 40 samples (~20% of the total of 201 samples) on the lower 
left side in 2c against 40 samples on the upper right side in a Student t test.
 -1       0             1 BMC Genomics 2007, 8:336 http://www.biomedcentral.com/1471-2164/8/336
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we used 25% or 5% of "top genes", and always found that
with the 5% top genes the intermediate ratings are more
"stretched out" than with 25% of top gene (not shown),
as one would expect, because the strongest pH-sensitive
genes are more powerful in distinguishing subtle differ-
ences in intermediate grades of membership. We ran the
Principal Component Analysis for six regions separately
and defined the strongest Type 1/2-like samples for each
region. When we subsequently compared the strongest
Type-1 against the strongest Type-2 samples and ranked
genes by their t scores, the top 5% or 25% genes are simi-
lar across the six regions as their t scores are highly corre-
lated across regions [see Additional File 5]. On average, a
top (or bottom) 10% gene in one region has a 57%
chance to be among the top (or bottom) 10% in another
region. We ranked genes by their average t score ranks in
five regions (all except CB, as cerebellum is an outlier
region for gene expression due to its unique anatomical
and physiological properties), and listed the 1000 most
strongly up-regulated and 1000 most strongly down-regu-
lated genes in Additional File 6. Genes in these lists can be
used as most informative genes in future, independent
studies.
Agonal Stress Ratings
Because the PC1 scores successfully arrange the samples
into a smooth gradient, these scores by themselves could
serve as a measure of agonal stress in individual samples.
However, we found that PC1 may be strongly influenced
by the scale of variance in individual chips and sometimes
by a small number of "outlier" samples, whereas our
method of using PC1 as a crude criteria to pre-select the
strongest ~20% Type 1- and Type 2-like samples is more
robust to these outliers. In addition, the interpretation of
the Principal Component scores requires the notion of
decomposition of the observed gene expression patterns
into the linear combination of multiple components. This
interpretation is most natural in cases where each sample
represents the actual mixing of multiple cell types, each
having its own canonical expression patterns. The mean-
ing of PC scores is also complicated by the process of ana-
lyzing log-transformed signal values, while actual
transcript levels are "mixed" on the linear scale. Alterna-
tive indices, such as the probability of classification [25],
or the prediction strength such as the "margin-of-victory"
measures adopted in Golub et al. [27], are most appropri-
ate when there are multiple genuinely discrete outcomes,
for which what is uncertain is the strength of evidence for
class assignment. In our case, gene expression in the brain
is most likely affected by agonal stress in a graded (albeit
non-linear) fashion. Although many of the samples
belong to the two extreme states–one is minimally
affected by stress, the other for samples that have con-
verged to the quasi-steady state of "thoroughly affected"–
some tissues in our collection are apparently sampled at
an intermediate physiological state, and can best be char-
acterized by the sample's relative distance to the two ends
of the spectrum, that is, the distance to the prototypical
normal-pH pattern minus the distance to the prototypical
low-pH pattern, where "distance" can be the Pearson's
correlation, Euclidean Distance, Spearman's rank correla-
tion, or a number of other metrics. The Agonal Stress Rat-
ing is thus defined as the difference between each sample's
distances to the two prototypical patterns, and can be cal-
culated by using different sets of most informative genes,
which in turn can be defined by comparing the most
extreme samples (see Methods). Although ASR is formally
neither a probability of classification nor a mixing ratio, it
is actually quite similar to these other measures as most of
them are variants of the linear discriminant function.
A comparison of the median ASR values (for each subject,
across regions and sites) with tissue pH (Figure 4) reveals
two features. First, there is a general correlation, i.e., low
pH samples tend to have low ASRs. Secondly, there is con-
siderable local discrepancy, i.e., among the normal pH
samples, the ASR-pH correlation is weak. These discrepan-
cies imply that the ASR values, which are derived directly
from the gene expression data, are sometimes at odds with
the measured brain pH. In the face of such discrepancies,
we need to determine which index is a more accurate sur-
rogate for the actual degrees of stress experienced by the
individual subjects in specific brain regions, and therefore
provides a safer control of the agonal stress confounder.
We examined a test case: from a set of 55 AnCg samples
previously "included" in an intermediate-stage analysis,
we selected all of the thirteen Control samples with ASR >
0.8, and divided all of the fourteen Major Depression
samples into two groups (Figure 5a): one that was
matched with the 13 Controls in pH (6.91 +/- 0.13 in con-
trols, 6.87 +/- 0.11 in cases, p = 0.45, t test) but not in ASR
(1.25 +/- 0.27 in controls, 0.18 +/- 0.44 in cases, p =
0.0003), another matched to the Controls in ASR (1.25 +/
- 0.27 in controls, 1.14 +/- 0.18 in cases, p = 0.28) but not
in pH (6.91 +/- 0.13 in controls, 7.13 +/- 0.08 in cases, p
= 0.00015). We carried out MDD-Control comparisons
for the two MDD groups separately, and analyzed the top
and bottom 4,000 genes in EASE (the Expression Analysis
Systematic Explorer) [28] for significantly enriched Gene
Ontology terms. Figure 5b shows that the pH-matched
comparison yields the gene families and pathways associ-
ated with agonal stress that we and others previously dis-
covered, whereas the ASR-matched group significantly
reduces the effect. This result is not surprising, as by the
definition of ASRs, we effectively have balanced the key
stress-related pathways when we match samples by ASR.
This test case, however, shows that matching by pH is not
always safe for guarding against the agonal stress con-
founder, whereas the empirically derived ASR values pro-
vide a more accurate assessment of the regulatoryBMC Genomics 2007, 8:336 http://www.biomedcentral.com/1471-2164/8/336
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responses to near-death stress in individual samples, and
allow a more stringent control. In a section below we will
describe the robustness ASRs, particularly the finding that
deriving ASRs by using only the control samples did not
substantially change the result.
Between-region differences
After calculating ASR for all six regions and for two sites in
each region, we obtained twelve series of ASR values. As
AMY and CB had larger numbers of missing chips (sam-
ples not analyzed on microarrays), we plotted the eight
ASR series for the four remaining brain regions in color
codes along with pH values and AFS (in two levels) (Fig-
ure 6, see figure legend for color codes), with the samples
sorted by pH (high pH on the top of the figure), and miss-
ing data in white. This figure has several broadly recogniz-
able features. First, ASR results from the two sites tend to
agree, although not always so. Secondly, ASRs in most
samples tend to be correlated across the four regions,
reflecting brain-wide patterns. Thirdly, the ASR scores
show a coarse correlation with pH and the clinical AFS
scores, as samples at the bottom of the figure are generally
those with both low pH and low ASR (this can also be
seen in Figure 4, where pH is plotted against the median
ASR across the six brain regions). The correlations
between pH and ASR, across all 126 samples, range from
0.3 to 0.6 among the twelve ASR series (from 0.57 to 0.63
in AnCg, DLPFC, CB, and NACC, 0.47 in HC, and 0.3 in
AMY, which has the smallest sample size: 66 out of 126
total samples. Note that pH was measured in CB). But
Correlation of ASR and pH values Figure 4
Correlation of ASR and pH values. Median ASR values across 2–3 sites and six brain regions for 126 subjects versus their 
brain pH values. Samples indicated in red and black were in general agreement between pH and ASR. The eight samples in blue 
were previously removed from analysis due to either low pH or some clinical complications (AFS is non-zero), but had normal 
ASR values and likely had not experienced significant agonal stress. The eight samples shown in green were previously included 
but had low ASR values, and should better be removed in order to reduce sample heterogeneity and possible case-control 
imbalance.BMC Genomics 2007, 8:336 http://www.biomedcentral.com/1471-2164/8/336
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Comparing pH-matching and ASR-matching with an example Figure 5
Comparing pH-matching and ASR-matching with an example. a. ASR and pH values for samples used in a test case, 
where a group of pH-matched major depression samples (in blue) were compared to controls (in red), while a second group of 
ASR-matched major depression samples (in green) were compared to the same controls. b. In an analysis of enrichment of 
Gene Ontology and KEGG pathway terms for the top genes, the pH-matched comparison still revealed significant effects for 
gene families and pathways known to be affected by the pH effect, while the same effect was much attenuated in the ASR-
matched comparison.
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B 
0.92 6.1E-05 defense response GO Biological 
Process
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immune response GO Biological 
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Region-region difference of ASRs Figure 6
Region-region difference of ASRs. A color-coded table of (from left to right) pH values (red is higher pH), AFS scores (0 
complication in red, AFS = 1 in light blue), and eight series of ASR values (red-higher ASR) for 68 subjects satisfying pH>6.6 and 
at most two missing values out of eight ASR series. The eight ASR columns represented four brain regions, each measured in 
two sites. Tan-colored elements indicate missing data because the samples were not run.
pH  AFS  ACG         DLPFC          HC          NACC   BMC Genomics 2007, 8:336 http://www.biomedcentral.com/1471-2164/8/336
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these correlations are much smaller when using only the
90 pH>6.61 samples, indicating that much of the correla-
tion was driven by the large differences between the high-
pH and the low-pH samples. Finally, some of the subjects
who had normal pH yet low ASR can be explained by hav-
ing clinically recorded agonal stress (AFS = 1 or higher).
However, beyond these large trends, there remain striking
between-region differences in many individual subjects.
For example, the first subject from the top, indicated by
the first arrow on the right, has low ASRs (in green) in
AnCg, and normal to high ASRs in the other regions. The
third and sixth subjects, indicated by the next two arrows,
have unusually low ASRs in DLPFC and HC, respectively.
These strong region-region differences in ASRs are
robustly observed (see the next section) and suggest gen-
uine differences in stress outcome across different parts of
the brain. Such differences may arise due to inter-individ-
ual variabilities in local structure or function, resulting in
region-specific vulnerability to agonal stress. An addi-
tional possibility is that the nature of the illness that
caused the death, such as hepatic, renal, or cardiac fail-
ures, may have triggered a region-specific brain response.
These results underscore the value of using ASRs to carry
out per-region sample matching, as pH and clinical indi-
cators are measures for the entire brain.
Robustness of ASRs
It is difficult to know how much between-region differ-
ences arise from variabilities in tissue dissection, but this
factor is unlikely to explain most of the differences we
observed here, as the effect is seen even for relatively large,
easy-to-dissect regions such as DLPFC and CB. Although
the nature of the observed regional differences is still not
clear, most of such differences are likely due to actual bio-
logical differences rather than to technical variability in
performing RNA labeling and hybridization or to data
analysis methods. There are several reasons for making
this conclusion. First, while regional differences of ASRs
are often large (+/- 0.5), ASRs varied to a much lesser
degree (1) between sites, (2) between different numbers
of informative genes used, (3) between different distance
measures (correlation, rank correlation, or Euclidean dis-
tance), (4) with another round of normalization after
median centering, (5) following the selection of only the
high ASR samples as the basis for re-calculating block
medians, or (6) importantly, following the use of only
normal controls rather than both cases and controls for
ranking genes by t scores. Secondly, we examined the pos-
sibility that some regions may actually have a greater Type
1-Type 2 difference than the other regions, and different
samples may have different regional differences. To this
end, we calculated additional versions of ASR by using (1)
the same ten Type 1 samples and the same 14 Type 2 sam-
ples to determine the informativeness of genes in all six
regions; (2) combined all six regions (more than 1200
chips) in designating the canonical samples on the two
extremes, defining most informative genes, and calculat-
ing ASR across all 1200 samples (all regions together).
These alternative versions did not significantly alter the
ASR patterns across samples and regions, and did not
explain most of the observed regional differences. Thirdly,
with our 700-gene Illumina data, we were able to compare
the ASRs based on data from two different platforms. For
each sample, we averaged the Affymetrix ASR values from
two sites to obtain the six values for six regions, and calcu-
lated their correlation to the corresponding six ASR values
from the Illumina data. We obtained 67 such correlations
in 67 samples for which we had both the Affymetrix and
Illumina data. Of these 67, 58 correlations were above
0.33, 43 were above 0.67, and 28 were above 0.8, with
most of the smaller correlations explained by very low
between-region variations, that is, when the six scores are
similar to begin with for a given sample, it is more difficult
to observe a highly correlated pattern for this sample in a
different platform.
Discussion
Many gene expression analyses have shown that agonal
stress at the time of death can significantly alter expression
patterns in postmortem tissues [29-33]. Because of this,
comparative studies that rely on postmortem material
must take every precaution to ensure that cases and con-
trols are properly balanced with regard to this well-estab-
lished confounder. What remains unclear, however, is to
what extent residual imbalance still accounts for the most
significant findings. The study presented here is motivated
by two considerations. First, a dichotomous classification
of good-quality versus bad-quality samples is often inad-
equate in assuring that cases and controls are well
matched among the "good samples". Secondly, clinical
variables such as AFS and continuous variables such as tis-
sue pH have several practical limitations, both in terms of
accuracy and in their inability to assess each brain region
separately. To address these concerns, we developed a rat-
ing metric to infer agonal stress based on expression data,
and strongly advocated a conservative approach that uses
these empirical ratings to select a homogeneous group or
to balance cases and controls. The adoption of continuous
ratings instead of the more commonly used categorical
assignment is expected to bring several advantages: pro-
viding a more reliable measurement of underlying heter-
ogeneity that does not show natural boundaries, retaining
important information regarding sub-threshold variabil-
ity, and allowing flexible integration with other variables.
Between-region differences
Our results revealed striking between-region differences in
stress outcome. This complexity presents additional chal-
lenges to gene expression analyses of the brain, especiallyBMC Genomics 2007, 8:336 http://www.biomedcentral.com/1471-2164/8/336
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if the goal is to not only study each region separately, but
also to study biological regulation across brain regions, as
well as their disruption in the diseased state. During our
initial analysis, we had hoped that all regions of the same
brain would have a similar stress profile, making it possi-
ble to use one or more regions as the same-subject control
for the other regions. In this scheme, between-region dif-
ferences in gene expression, instead of gene expression
levels in each region separately, are compared between
cases and controls, under the assumption that agonal
stress is acting more extensively across the entire brain,
whereas expression signatures of psychiatric disorders are
restricted in some regions. This approach is reminiscent of
the genetic method of using family controls to remove the
impact of population structure. Our analysis, however,
revealed considerable heterogeneity between brain
regions in stress-related expression patterns, suggesting
that this between-region analysis method is still problem-
atic and requires further investigation.
The need for a conservative approach
One of the concerns in adopting this approach is that gene
expression changes in response to near-death conditions
may overlap with those affected by chronic psychiatric
states. If the Agonal Stress Ratings reflect the blending of
both effects, how do we know whether we have under- or
over-corrected the main effect of interest? Unfortunately,
at the present time we do not know many genes or path-
ways that are clearly and reproducibly altered by major
depression and bipolar disorder; as a result we currently
do not have a definitive set of "true positives" to fine-tune
the stringency of the sample matching strategy. To address
this type of question would require a sufficiently large col-
lection of samples to directly investigate whether patients
of mental disorders are more likely than the healthy con-
trols to have more severe terminal stress, lower tissue pH
values, and more pronounced changes in gene expression
patterns. When the sample size is below or near 100, as is
currently the norm in expression profiling of human
brains, a study is not properly powered to formally answer
this question, and the gene expression signature due to
mental disorders, if it overlaps with that due to agonal
stress, will be easily obscured. However, despite this
uncertainty, it is widely recognized that the effects due to
agonal stress usually have a much more potent influence
on gene expression patterns than do mental disorders. In
such a situation, the chance of finding false positives due
to residual imbalance is quite high. A continuous, quanti-
tative rating system, like the ASR that we developed here,
can greatly reduce the number of false positives in such
studies by allowing a quantitative assessment of the
broadly recognizable outcome of the most prominent
confounder. By applying the ASR, it remains possible to
detect a true signal for psychiatric disorders as long as it is
strong enough or sufficiently independent of the con-
founding effect, particularly if the disease related changes
involve a small number of transcripts whereas the agonal
conditions usually affect a large number of genes [6]. In
essence, the practice of sample matching by data-derived
indices constitutes a higher standard for a "true positive",
requiring that its main effect (for psychiatric disorders) to
rise above its potential colinearity with the major extrane-
ous covariates (changes due to agonal stress). The situa-
tion is analogous to the case of a genetic association study
of, for example, cardiovascular disorders, where the goal
is typically to detect genetic association with the disease
while adjusting for the traditional risk factors, such as
blood pressure, diabetes, body-mass index, and serum
levels of HDL and triglyceride [34]. Because these tradi-
tional risk factors are also influenced by genetic variation,
making such corrections constitutes a more focused goal:
to discover genetic contribution to the disease independent
of the genetic basis of the other risk factors, even though in the
long run it is ideal to be able to study all the contributing
factors in conjunction with each other. By the same token,
the near-term goal of our study is to discover gene expres-
sion signatures of psychiatric disorders independent of
gene expression changes due to confounding factors, espe-
cially when these factors (stress at death) are not likely to
be closely related to the biology of mental illness.
Conventional versus empirical indicators
In this study, we found that the Agonal Stress Ratings are
sometimes at odds with tissue pH values or clinically-
recorded medical factors. These indices, though useful in
most situations, have several shortcomings when serving
as surrogates for the underlying biological heterogeneity.
First, different brain regions may carry different stress out-
comes, while pH values were usually measured in one
region. Likewise, the clinical indicators do not inform
regional heterogeneity. Secondly, these conventional var-
iables inevitably contain measurement errors or incom-
plete information. Thirdly, brain pH is both the outcome
of prior episodes of stress and the trigger for subsequent
physiological responses. As a result, even if pH is meas-
ured in all regions, and even if pH is similar across regions
[32], the samples that have similar pH are still not likely
to have a uniform stress-induced gene expression profile.
For these reasons, we recommend using ASR as a primary
criterion in sample selection and sample matching, anal-
ogous to using inferred ancestry in genetic association
studies [15].
It is also important to point out that the tissue pH meas-
urements and clinical records are still of immense value in
sample matching. They provide biological meaning to the
ASR values, and allow an integrated strategy that com-
bines these different indicators in sample selection [35].
We believe that future studies need to continue collecting
clinical information as extensively as possible, and if fea-BMC Genomics 2007, 8:336 http://www.biomedcentral.com/1471-2164/8/336
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sible, measure pH in multiple brain regions to directly
assess regional differences of degree of stress.
Assumption of neutrality
An implicit assumption of using inferred ancestry to con-
trol population stratification in genetic studies is that
most of the genetic markers tested are phenotypically neu-
tral; that is, not associated with the disease under study.
Under this assumption, when data have been collected for
a large number of loci (that is, not just for a few candidate
genes), the majority of these loci can be used to infer pop-
ulation structure [14,16,36,37]. Alternatively, they can be
used as Genomic Control loci to detect over-dispersion of
the standard test statistics due to stratification [38-40].
This assumption of neutrality generally holds when we
expect to detect large or moderate signals of association
for only a small number of causative genes. In gene
expression analysis, however, it is possible that a consid-
erable proportion of the transcripts are affected both by
the extraneous confounders such as agonal stress and by
the disease being studied. As a result, some of the genes
used to infer agonal stress may also be associated with the
disease, making it difficult to separate the two effects.
However, this apparent difference between genetic and
gene expression studies depends on the actual context of
the study. Population stratification can be a very strong
confounder for traits or diseases that have subtle genetic
effects but large population differentiation (in incidence
rates as well as in allele frequencies), or are studied in
recently admixed population where chromosomal seg-
ments of defined ancestry can be as long as 5 cM [41]. In
these situations, a substantial fraction of genetic markers
may show weak association, while most of such signals
may disappear after correcting for inferred individual
ancestry or locus-specific ancestry. For both gene expres-
sion and genetic studies, using the data per se to detect
sample heterogeneity is a practically useful yet ultimately
exploratory method, especially when true positives are
not known beforehand.
Model considerations and the need for canonical patterns
In inferring individual ancestry from genetic data, it is
helpful to know the genetic profile of the putative ances-
tral populations, for example, the allele frequencies deter-
mined from samples that represent the progenitors of the
admixed individuals. Without these "pure" canonical pro-
files, while it is still theoretically possible to simultane-
ously determine both the canonical ancestral patterns and
the mixing ratios of each sampled individual, the results
are less reliable and often improperly scaled [16]. Simi-
larly, our strategy to derive Agonal Stress Ratings relies on
having obtained data for both "normal" tissues and
severely stressed tissues. These opposing extremes serve as
the two reference points to measure the grades of mem-
bership in between. Hypothetically, in a different study, if
none of the samples (or too few of them) are from the
severely stressed low-pH samples, the canonical signature
of the confounder (or the principal components) would
be much less precisely defined. However, even when the
absolute values of ASR only scale from "normal" to mildly
stressed, the relative ratings among samples can still be
used as the empirical basis for sample matching, or as the
basis for a variety of post hoc strategies, such as stratified
analysis, or incorporating covariates in regression analy-
sis. We have found that the main differences due to agonal
stress can be robustly observed, i.e., are highly similar
between study sites and across two microarray platforms.
This means that the canonical patterns that we describe
here, featuring prominently energy metabolism genes and
stress response pathways, can be transferred to other stud-
ies of postmortem tissues even if these studies character-
ized a narrower range of the confounding effect. In
Additional files 3 and 6 we provide the genes most
strongly affected in our dataset; these genes can be used as
informative stress markers for pre-evaluating future sam-
ple collections, even before microarray experiments. The
parallel example in genetic studies is that one can profile
the genetic signature for a few major continent groups
(such as in the International HapMap Project) and use
this information repeatedly to infer admixture in individ-
uals from a heterogeneous population such as the African
Americans, sometime by using a small number of most
informative genetic markers [26]. We also wish to empha-
size that using only the controls to define the two canon-
ical expression patterns did not change the ASR ratings in
any meaningful way, reflecting the fact that the case-con-
trol differences are far subtler than the stress-related differ-
ences.
The situation would be much simpler if the mixing ratios
are known by other, independent methods, or if the
canonical patterns were profiled in independent studies.
Such an "expression signature bank" can be established by
studying the response to controlled stress treatment in
animal models, or by analyzing "pure" classes of brain
cells, such as laser-captured defined cell populations. Stu-
art et al. [42] gave an example where the mixing ratio is
known for tumor samples when tissue pathologists
reported a priori the fractional composition of different
cell types in each sample. Conversely, Lu et al. [43] used
expression data for synchronized yeast cells in defined
phases to infer mixing ratios of asynchronized samples–
this is a case where the basic patterns were known, with
mixing ratios being the target of inference. When neither
is known, as in our case, the solution cannot be arrived at
analytically but can be optimized iteratively. For example,
several methodology studies [44-46] have implemented
variants of the Expectation-Maximizing (EM) algorithm
to simultaneous search for the unknown canonical pat-
terns and the unknown mixing ratios in gene expressionBMC Genomics 2007, 8:336 http://www.biomedcentral.com/1471-2164/8/336
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data. Similar methods, including ones involving Markov
Chain Monte Carlo methods, have been developed for
inferring individual's genetic ancestry [14,16,47]. In our
dataset, as the principal pattern is relatively strong, we
expect the result to converge quickly and decide to adopt
a simple definition of ASR. In more complicated situa-
tions, for example, when the second or higher Principal
Components can be interpreted as signatures of other
confounders such as age, medication, or cell types, it
would be important to apply these more sophisticated
algorithms.
Conclusion
In this study we developed an Agonal Stress Rating (ASR)
system that evaluates each sample's degree of stress based
on gene expression data, and used ASRs in post hoc sample
matching. We found that ASR-based matching provides
tighter control of the agonal effect than by using pH. We
also found that different brain regions exhibited different
stress outcomes and that such regional patterns also var-
ied between individuals. Our results once again highlight
one of the main challenges in gene expression studies of
psychiatric disorders: transcript levels are under the influ-
ence of a large number of confounding factors. Agonal
stress undoubtedly plays a major role; as a result the
stress-related, pH-sensitive genes or pathways are prone to
appear as the top findings in case-control comparisons.
We propose to adopt a conservative approach for the
genes and pathways that are clearly altered by the con-
founding factors, even if it is possible that they are also
influenced by the disease of interest. Deriving an ASR
from gene expression data and using it for sample match-
ing is one example of such an approach. This approach
involves using continuous ratings as opposed to categori-
cal assignments, thus represents an early attempt to apply
graded classification methods to a sample heterogeneity
problem for brain tissues, similar to the application of
dimensional models in psychiatric diagnosis. In practice,
we believe that this method can and should be expanded
to the characterization of other sources of biological vari-
ation, such as medication, age, and cell-type composition
of the dissected brain tissues. Drug use by psychiatric
patients is likely to affect gene expression, regardless
whether the medication was effective in treating the dis-
ease or not. But medication history is one of the most elu-
sive aspects of clinical information to accurately record
and quantify. Likewise, an individual's chronological age
may vary greatly from the actual physiological age of the
tissue under study, while the neuronal-glial ratios of the
dissected tissues may also vary from brain region to brain
region, from subject to subject. Proper monitoring of
these additional sources of phenotypic variation is an
important prerequisite for the eventual identification of
the true gene expression signature of mental disorders,
and in this regard, animal models of either drug treatment
or stress, independently applied, in the absence of psychi-
atric history and genetic heterogeneity, represents a pow-
erful alternative strategy for defining canonical expression
patterns and assessing their relative contributions.
Methods
Sample acquisition, RNA labeling, and microarray hybrid-
ization were carried out as described previously [6,48]. We
used RMA [49] to obtain the probe set summary values for
the Affymetrix U133A and U133Plus_2 Genechips. We
removed chips that were clearly outliers, or failed the
"gender-test", in which we confirm that Y-chromosome
transcripts are only detected in male samples. The entire
dataset, consisting 1218 Genechips, has been deposited to
the Gene Expression Omnibus [50] with the Accession
Number GSE6306.
Since the original Affymetrix probe definitions require fre-
quent updates, and are known to contain errors and
redundancies, we developed a custom probe definition
method that involves re-annotating all Affymetrix probes
by sequence alignment to the most recent build of
genomic DNA sequences and a variety of transcribed
sequence collections, including Unigene, Refseq,
ENSEMBL Genes/Transcripts/Exons, and Entrez, etc [51].
For each of these transcript definition systems, the probes
that could be uniquely assigned to their transcript targets
were assembled in custom Channel Definition Files (CDF
files) as individual probe sets, which assumed the names
of the matched transcripts, thus replacing the Affymetrix
probe set ID's. The analysis presented here used the third
generation of our Unigene-based CDF files, which were
based on Unigene Build 176. The CDF files can be down-
loaded for free at [52].
We calculated chip-chip correlation in each region by
using RMA summaries values and defined blocks by visual
inspection of the correlation heatmaps. Logged expres-
sion values for each gene were centered within each block.
Median centered values were used for the Principal Com-
ponent Analysis, whereby the PC1 scores were used to
rank samples so that a proportion of samples at one
extreme were designated canonical Type 1 samples, while
a proportion of samples at the other extreme were desig-
nated canonical Type 2 samples. These two groups of sam-
ples were compared by the Student's t test, so that all
genes can be ranked by the t scores. The ASR of each sam-
ple is then calculated as the "distance" to canonical Type
1 pattern minus its distance to the canonical Type 2 pat-
tern by using a proportion of the genes with the largest
absolute t scores. A range of parameter values were tested,
including different proportion of samples used to define
canonical patterns, different number of genes used for cal-
culating ASRs, and different measured of chip-chip dis-
tance. For example, most results in this report were basedBMC Genomics 2007, 8:336 http://www.biomedcentral.com/1471-2164/8/336
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on using approximately 20% of samples at each extreme
of PC1 scores, 25% of the genes of largest t scores, and
Pearson's correlation as distance measures. The nearest
Shrunken Centroid Classification was carried out by using
the Predictive Analysis of Microarrays (PAM) package in
R. All R scripts used in the analysis are available from the
authors.
The Illumina custom Beadchips were designed to cover
~700 transcripts that represent both biologically candi-
date genes and preliminary Affymetrix results to be vali-
dated. Sample labeling and hybridization were performed
according to manufacturer's specifications. In all, about
67 samples were analyzed in each brain region, except for
AMY, which we analyzed only 54 samples. All of the
nearly 400 RNA samples were randomized with regard to
cohort and region. The calculation of ASRs was carried out
in a similar fashion as with the Affymetrix data except that
there were only 700 genes used in the analysis.
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Additional material
Additional file 1
Technical batch effects. a. The color-coded correlation matrix among the 
same 201 AnCg samples as in Figure 1a, but calculated by using only the 
68 control probe sets targeting spiked-in E. coli transcripts. Sample order 
was the same as in Figure 1a. b. Similar correlation heatmap based on 
700-gene Illumina data. Samples were ordered by Cohort. c. Correlation 
matrix among 24 chips that represented eight samples ran three times 
each. The first time (samples 1–8 counting from lower left) was on 
U133A chips; the next two times were on U133_Plus2 chips. Shown are 
results after median centering of the chip-type blocks. The off-diagonal 
lines of high similarity are for the three replicate chips of the same sam-
ples, indicating that sample-sample differences were reproducibly meas-
ured across two chip types after removing the block effect.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-336-S1.pdf]
Additional file 2
Heatmap of normalized expression levels for "top 25%" genes in 201 
AnCg samples. Shown are log-transformed, normalized expression levels 
of 3184 transcripts across 201 AnCg samples. These genes have the high-
est 25% of Type 1- Type 2 absolute t scores, and have been used to calcu-
late the sample-sample correlations shown in Figure 3, upper left panel. 
The genes are ordered from left to right by their coefficients in the first 
principal component (i.e., each gene's "loading" in the first eigenvector), 
whereas the samples are ordered from top to bottom by their first principal 
component scores. The color scale is for log2 values of -3 (8-fold lower 
expression) to 3 (8-fold higher), with some values in the upper left corner 
being greater than 3. These saturated values were shown in brown.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-336-S2.pdf]
Additional file 3
Expression levels of 3841 most changed genes. Normalized expression lev-
els for 3841 genes in 201 samples as shown in Additional File 2. Samples 
and genes are ordered by PC results, and formatted in Treeview format.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-336-S3.cdt]
Additional file 4
Cross-validation errors in classifying samples. Number of cross-validation 
errors as a function of number of genes used in the nearest Shrunken Cen-
troid classification [25] where the 201 AnCg samples were analyzed, and 
the Type 1-Type 2 designations were taken as known. Lower panel showed 
the errors for Type 1 and Type 2 samples separately.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-336-S4.pdf]BMC Genomics 2007, 8:336 http://www.biomedcentral.com/1471-2164/8/336
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